[go: up one dir, main page]

GB0314048D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0314048D0
GB0314048D0 GBGB0314048.0A GB0314048A GB0314048D0 GB 0314048 D0 GB0314048 D0 GB 0314048D0 GB 0314048 A GB0314048 A GB 0314048A GB 0314048 D0 GB0314048 D0 GB 0314048D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0314048.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER Ltd
Pfizer Ltd Great Britain
Original Assignee
PFIZER Ltd
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27636730&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB0314048(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd
Priority to GBGB0314048.0A priority Critical patent/GB0314048D0/en
Publication of GB0314048D0 publication Critical patent/GB0314048D0/en
Priority to JP2006516540A priority patent/JP4137159B2/ja
Priority to SI200430767T priority patent/SI1638933T1/sl
Priority to AU2004247487A priority patent/AU2004247487B2/en
Priority to AP2005003467A priority patent/AP2005003467A0/xx
Priority to PCT/IB2004/001943 priority patent/WO2004110995A1/en
Priority to YUP-2005/0924A priority patent/RS20050924A/sr
Priority to BRPI0411594-5A priority patent/BRPI0411594A/pt
Priority to AT04736241T priority patent/ATE398107T1/de
Priority to DK04736241T priority patent/DK1638933T3/da
Priority to CA002530159A priority patent/CA2530159C/en
Priority to DE602004014372T priority patent/DE602004014372D1/de
Priority to EP04736241A priority patent/EP1638933B1/en
Priority to EA200501730A priority patent/EA009881B1/ru
Priority to CNA2004800172229A priority patent/CN1835921A/zh
Priority to MXPA05013960A priority patent/MXPA05013960A/es
Priority to OA1200500363A priority patent/OA13178A/en
Priority to KR1020057024147A priority patent/KR100803796B1/ko
Priority to ES04736241T priority patent/ES2305776T3/es
Priority to PT04736241T priority patent/PT1638933E/pt
Priority to NZ544046A priority patent/NZ544046A/en
Priority to PL04736241T priority patent/PL1638933T3/pl
Priority to HR20050993A priority patent/HRP20050993A2/hr
Priority to HR20080339T priority patent/HRP20080339T3/xx
Priority to PE2004000590A priority patent/PE20050631A1/es
Priority to UY28360A priority patent/UY28360A1/es
Priority to GT200400121A priority patent/GT200400121A/es
Priority to PA20048605301A priority patent/PA8605301A1/es
Priority to ARP040102082A priority patent/AR044715A1/es
Priority to TW093117317A priority patent/TW200505852A/zh
Priority to US10/872,160 priority patent/US7378436B2/en
Priority to NL1026438A priority patent/NL1026438C2/nl
Priority to UAA200511011A priority patent/UA80338C2/uk
Priority to ZA200509132A priority patent/ZA200509132B/xx
Priority to IL172063A priority patent/IL172063A0/en
Priority to IS8136A priority patent/IS8136A/is
Priority to EC2005006232A priority patent/ECSP056232A/es
Priority to MA28674A priority patent/MA27885A1/fr
Priority to TNP2005000321A priority patent/TNSN05321A1/fr
Priority to NO20060190A priority patent/NO20060190L/no
Priority to US12/124,755 priority patent/US20080306123A1/en
Priority to CY20081100869T priority patent/CY1110434T1/el
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0314048.0A 2003-06-17 2003-06-17 Novel compounds Ceased GB0314048D0 (en)

Priority Applications (42)

Application Number Priority Date Filing Date Title
GBGB0314048.0A GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds
AU2004247487A AU2004247487B2 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
EP04736241A EP1638933B1 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
PT04736241T PT1638933E (pt) 2003-06-17 2004-06-07 Derivados de n-pirrolidin-3-il-amida como inibidores de recaptação de serotonina e noradrenalina
PL04736241T PL1638933T3 (pl) 2003-06-17 2004-06-07 Pochodne n-pirolidyn-3-yloamidu jako inhibitory wychwytu zwrotnego serotoniny i noradrenaliny
HR20080339T HRP20080339T3 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
AP2005003467A AP2005003467A0 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-YL-amide derivatives as serotonin and noradrenaline reuptake inhibitors.
PCT/IB2004/001943 WO2004110995A1 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
YUP-2005/0924A RS20050924A (sr) 2003-06-17 2004-06-07 N-pirolidin-3-il-amid derivati kao inhibitori resorpcije serotonina i noradrenalina
BRPI0411594-5A BRPI0411594A (pt) 2003-06-17 2004-06-07 derivados de n-pirrolidin-3-il-amida como inibidores de re-absorção de serotonina e noradrenalina
AT04736241T ATE398107T1 (de) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme
DK04736241T DK1638933T3 (da) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amid-derivater som serotonin- og noradrenalin-genoptagelses inhibitorer
CA002530159A CA2530159C (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
DE602004014372T DE602004014372D1 (de) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide-derivate als inhibitoren der serotonin- und noradrenalin-wiederaufnahme
SI200430767T SI1638933T1 (sl) 2003-06-17 2004-06-07 Derivati N-pirolidin-3-il-amida kot inhibitorji ponovnega privzema serotonina in noradrenalina
EA200501730A EA009881B1 (ru) 2003-06-17 2004-06-07 Производные n-пирролидин-3-ил-амида в качестве ингибиторов обратного захвата серотонина и норадреналина
CNA2004800172229A CN1835921A (zh) 2003-06-17 2004-06-07 用作5－羟色胺和去甲肾上腺素再摄取抑制剂的n－吡咯烷－3－基－酰胺衍生物
MXPA05013960A MXPA05013960A (es) 2003-06-17 2004-06-07 Nuevos compuestos.
OA1200500363A OA13178A (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors.
KR1020057024147A KR100803796B1 (ko) 2003-06-17 2004-06-07 세로토닌 및 노르아드레날린 재흡수 억제제로서의ｎ-피롤리딘-3-일-아미드 유도체
ES04736241T ES2305776T3 (es) 2003-06-17 2004-06-07 Derivados de n-pirrolidin-3-il-amida como inhibidores de la re-captacion de serotonina y noradrenalina.
JP2006516540A JP4137159B2 (ja) 2003-06-17 2004-06-07 セロトニン及びノルアドレナリン再取り込み阻害薬としてのｎ−ピロリジン−３−イル−アミド誘導体
NZ544046A NZ544046A (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
HR20050993A HRP20050993A2 (en) 2003-06-17 2004-06-07 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
PE2004000590A PE20050631A1 (es) 2003-06-17 2004-06-14 Compuestos derivados de amina como inhibidores de la reabsorcion de serotonina y de noradrenalina
UY28360A UY28360A1 (es) 2003-06-17 2004-06-14 Nuevos compuestos
GT200400121A GT200400121A (es) 2003-06-17 2004-06-15 Nuevos compuestos
TW093117317A TW200505852A (en) 2003-06-17 2004-06-16 Novel compounds
PA20048605301A PA8605301A1 (es) 2003-06-17 2004-06-16 Nuevos compuestos
ARP040102082A AR044715A1 (es) 2003-06-17 2004-06-16 Compuestos tipo amidas que inhiben la reabsorcion de las monoaminas
US10/872,160 US7378436B2 (en) 2003-06-17 2004-06-17 Compounds
NL1026438A NL1026438C2 (nl) 2003-06-17 2004-06-17 Nieuwe verbindingen.
UAA200511011A UA80338C2 (en) 2003-06-17 2004-07-06 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors, processes for their preparation, pharmaceutical composition containing them
ZA200509132A ZA200509132B (en) 2003-06-17 2005-11-11 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
IL172063A IL172063A0 (en) 2003-06-17 2005-11-20 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors
IS8136A IS8136A (is) 2003-06-17 2005-11-21 N-pýrrólidín-3-ýl-amíð afleiður sem serótónín og noradrenalín endurupptöku hindrar
TNP2005000321A TNSN05321A1 (fr) 2003-06-17 2005-12-16 Derives de n-pyrrolidine-3-ylamide servant d'inhibiteurs de reabsorption de serotonine et de noradrenaline
MA28674A MA27885A1 (fr) 2003-06-17 2005-12-16 Derives de n-pyrrolidine-3-ylamide servant d'inhibiteurs de reabsorption de serotonine et de noradrenaline
EC2005006232A ECSP056232A (es) 2003-06-17 2005-12-16 Nuevos compuestos
NO20060190A NO20060190L (no) 2003-06-17 2006-01-12 <n-pyrrolidin-3-ylamidderivater som serotonin- og noradrenalingjenopptagningsinhbitiorer
US12/124,755 US20080306123A1 (en) 2003-06-17 2008-05-21 Novel compounds
CY20081100869T CY1110434T1 (el) 2003-06-17 2008-08-14 Παραγωγα ν-πυρρολιδιν-3-υλ-αμιδιου ως αναστολεις επαναπροσληψεως σεροτονινης και νοραδρεναλινης

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0314048.0A GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds

Publications (1)

Publication Number Publication Date
GB0314048D0 true GB0314048D0 (en) 2003-07-23

Family

ID=27636730

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0314048.0A Ceased GB0314048D0 (en) 2003-06-17 2003-06-17 Novel compounds

Country Status (9)

Country Link
CN (1) CN1835921A (sr)
GB (1) GB0314048D0 (sr)
GT (1) GT200400121A (sr)
NO (1) NO20060190L (sr)
OA (1) OA13178A (sr)
RS (1) RS20050924A (sr)
TN (1) TNSN05321A1 (sr)
UA (1) UA80338C2 (sr)
ZA (1) ZA200509132B (sr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008339351B2 (en) * 2007-12-19 2013-02-28 Sumitomo Dainippon Pharma Co., Ltd. Bicyclic heterocyclic derivative

Also Published As

Publication number Publication date
OA13178A (en) 2006-12-13
NO20060190L (no) 2006-01-12
GT200400121A (es) 2005-03-03
UA80338C2 (en) 2007-09-10
TNSN05321A1 (fr) 2007-07-10
CN1835921A (zh) 2006-09-20
ZA200509132B (en) 2007-02-28
RS20050924A (sr) 2008-04-04

Similar Documents

Publication Publication Date Title
GB0308114D0 (en) Novel compounds
GB0305918D0 (en) Novel compounds
GB0308186D0 (en) Novel compounds
GB0308185D0 (en) Novel compounds
GB0308333D0 (en) Novel compounds
GB0304424D0 (en) Novel compounds
EP1648885A4 (en) NEW CONNECTIONS
GB0305426D0 (en) Novel compounds
GB0302431D0 (en) Novel compounds
GB0304809D0 (en) Novel compounds
GB0302546D0 (en) Novel compounds
GB0314048D0 (en) Novel compounds
GB0304803D0 (en) Novel compounds
GB0305293D0 (en) Novel compounds
GB0301872D0 (en) Novel compounds
GB0301608D0 (en) Novel compounds
GB0302988D0 (en) Novel compounds
GB0303464D0 (en) Novel compounds
GB0303467D0 (en) Novel compounds
GB0304408D0 (en) Novel compounds
GB0301593D0 (en) Novel compounds
GB0304802D0 (en) Novel compounds
GB0301592D0 (en) Novel compounds
GB0301591D0 (en) Novel compounds
GB0304811D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)